BrightSpring Health Services filings document the operating results, governance, capital structure and material events of a public home- and community-based healthcare services company. Its 8-K reports include quarterly financial results, preliminary financial information, completed asset dispositions, underwriting agreements, secondary common stock offerings, company share repurchases and related registration-statement disclosures.
The company’s proxy materials cover annual meeting matters, director and governance disclosures, executive compensation and shareholder voting topics. BrightSpring filings also identify its Nasdaq-listed common stock under BTSG and its 6.75% Tangible Equity Units under BTSGU, providing formal disclosure around both operating performance and security structure.
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of equity grants, option activity, and share sales. On March 4, 2026, he exercised 220,000 stock options at $6.37 per share and sold 220,000 common shares at $41.15 per share in a registered public offering.
On March 4–5, 2026, he was awarded several blocks of stock options and restricted stock units (RSUs), including 458,008 options, 955,823 options, and 186,845 RSUs. Some options are fully vested, while others and the RSUs vest in twelve equal quarterly installments starting April 25, 2026. After these transactions, he directly owned about 1,023,880 common shares, plus additional option and share interests held indirectly through family trusts, for which he disclaims beneficial ownership beyond his economic interest.
BrightSpring Health Services Chief Financial Officer Jennifer A. Phipps reported multiple equity transactions. She sold 35,000 shares of common stock at $41.15 per share in a registered public offering that closed on March 4, 2026, while exercising 35,000 stock options at $6.37 per share.
She also acquired several equity awards. On March 5, 2026, she received 53,384 restricted stock units that vest in three equal annual installments beginning on January 25, 2027. Performance-based stock options granted in 2019 and 2020 vested after performance conditions were satisfied, and additional options vest over three years starting January 25, 2027. Following these transactions, she directly owned 196,840 shares of common stock and 130,860 stock options.
BrightSpring Health Services executive Robert Allen Barnes, President, Community Living, reported the vesting of previously granted performance-based stock options. On March 3, 2026, he acquired 35,331 stock options and 2,944 stock options at an exercise price of $0.00 per share through grant/award acquisitions.
According to the footnotes, no new stock options were awarded; the transactions reflect vesting of 2019 and 2020 performance options whose performance conditions were satisfied on March 4, 2026. After these vesting events, Barnes held 113,718 options in one award and 11,776 options in another.
BrightSpring Health Services major shareholder entities associated with KKR reported several transactions in the company’s common stock. An affiliated holder, KKR Phoenix Aggregator L.P., sold 19,715,000 shares in an underwritten public offering at a net price of $40.961 per share. After these transactions, affiliated entities reported holding 41,824,259 shares of common stock. Additional movements included in-kind distributions that allowed ultimate recipients to make charitable donations of shares, with Messrs. Henry R. Kravis and George R. Roberts each donating shares they received. The reporting persons collectively disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest.
KKR-affiliated entities reported several transactions in BrightSpring Health Services common stock. The main move was an open-market sale of 19,715,000 shares at a net price of $40.961 per share through an underwritten public offering, leaving tens of millions of shares still indirectly held.
Additional entries cover 402,773 shares reclassified in connection with this sale, plus two bona fide gifts of 49,295 and 31,918 shares. Footnotes explain that these shares were distributed in kind to partners and shareholders so that ultimate recipients, including Messrs. Henry R. Kravis and George R. Roberts, could donate shares to charity. The reporting entities collectively disclaim beneficial ownership beyond any pecuniary interest.
BrightSpring Health Services' major shareholder KKR Phoenix Aggregator L.P. has sold part of its stake through a large secondary offering. On March 2, 2026, selling stockholders agreed to sell 20,000,000 shares of common stock, including 19,715,000 shares from KKR Phoenix Aggregator L.P., to an underwriter at a net price of $40.961 per share, with the deal closing on March 4, 2026. After the transaction, KKR Phoenix Aggregator L.P. directly holds 41,824,259 shares, and KKR-affiliated entities and founders Henry R. Kravis and George R. Roberts may be deemed to beneficially own up to 41,938,202 shares, representing about 21.8% of BrightSpring’s 192,369,354 shares outstanding as of the offering’s closing. KKR Phoenix Aggregator L.P. entered a lock-up agreement restricting most additional sales of BrightSpring stock for 60 days from March 2, 2026, unless the underwriter consents.
BrightSpring Health Services entered an underwriting agreement for an underwritten secondary offering of 20,000,000 shares of common stock at $41.15 per share. All of these shares were sold by KKR and management selling stockholders, so BrightSpring itself did not receive the sale proceeds, other than cash from related stock option exercises.
As part of the same transaction, BrightSpring repurchased 1,464,807 shares of its common stock from the underwriter. The underwriter did not receive underwriting fees on the repurchased shares. The deal was conducted under an automatic shelf registration on Form S-3ASR, with customary representations, covenants, and indemnification provisions.
BrightSpring Health Services resale prospectus: the selling stockholders are offering 20,000,000 shares of common stock. The company will not receive proceeds from the resale other than proceeds from cash exercise of management options. The prospectus shows a public offering price of $41.15 per share and aggregate proceeds to the selling stockholders of approximately $819,220,000. Subject to the closing of the offering, BrightSpring intends to purchase concurrently 1,464,807 shares from the underwriter and cancel them; the Repurchase is contingent on the offering closing. Shares outstanding were 193,549,161 as of February 27, 2026; the document also reports an expected post-offering outstanding share count of 192,369,354 as of February 27, 2026 after giving effect to the Repurchase and certain option exercises.
BrightSpring Health Services, Inc. is registering 20,000,000 shares of common stock for resale by selling stockholders, including KKR Phoenix Aggregator L.P., pursuant to a preliminary prospectus supplement dated March 2, 2026. The company will not receive proceeds from these resales except for proceeds from the cash exercise of stock options by management selling stockholders.
The prospectus supplement states that, subject to closing this offering, BrightSpring intends to concurrently repurchase up to the lesser of $60 million and 10% of the aggregate size of the offering, with the repurchase price per share equal to the underwriter’s purchase price. The filing cites a closing sale price of $41.43 per share on February 27, 2026. Shares outstanding are listed as 193,549,161 prior to the offering and 192,385,936 after the offering and the Repurchase under the filing’s stated assumptions.
BrightSpring Health Services filed its annual report describing a nationwide platform delivering home and community-based pharmacy and provider services to complex Senior and Specialty patients. The company serves over 465,000 patients daily through about 10,500 clinical providers and pharmacists across all 50 states.
BrightSpring is reorganizing its portfolio by agreeing to divest its Community Living business for $835 million, treating it as discontinued operations and sharpening focus on home health, hospice, rehab, primary care, and integrated pharmacy. The report notes substantial indebtedness of approximately $2.6 billion and a highly competitive, heavily regulated reimbursement environment.